Recruiting

Observational Study

Sponsor:

Hercules

Code:

NCT06212479

Conditions

Cancer

Metabolic Disease

Aneurysm

Neurologic Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

MRI Scan

Study Details

Brief summary:

This is a prospective, single-arm, observational study capturing data from whole-body magnetic resonance imagining (WB-MRI) from up to 100,000 male and female subjects 18 years of age or older recruited at multiple clinical sites within the United States. Study subjects must meet a set of inclusion and exclusion criteria. Potential subjects arriving at the study sites will be evaluated for enrollment. It is the Principal Investigator's (PI) responsibility to enroll only subjects who satisfy the inclusion/exclusion criteria. Recruitment can occur by subject presentation at the sites for elective standard screening, word-of-mouth, flyers, healthcare professional (HCP) referrals, advertisement online, or any other means, subject to approval by the associated institutional review board (IRB) or ethics committee (EC) when applicable.

Conditions

Cancer

Metabolic Disease

Aneurysm

Neurologic Disorder

Study ID

NCT06212479

Start date

May 17, 2024

Status verified date

Apr, 2025

Completion date

Jan, 2037

Anticipated

Primary completion date

Jan, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Each subject MUST:

  • Be>=18 years of age at the time of enrollment.
  • Be able to read and understand provided procedural information for the study;
  • Be able and willing to follow all study procedures including proper breathing and body movement minimization while within the WB-MRI system;
  • Be willing and able to provide required clinical, demographic, medical history, and concomitant medications information;
  • Be able to provide financial payment in advance for reimbursement of the cost of the WBMRI acquisition procedure and interpretation;
  • Complete all required consent procedures.

Exclusion Criteria:

  • Harbor within their bodies contraindicated medical devices including, but not limited to, implanted pacemakers, intracranial aneurysm clips, cochlear implants, drug infusion pumps, neurostimulators, bone growth stimulators, certain intrauterine contraceptive devices, non- MRI safe metals, etc.;

  • Self-certify that they are pregnant;
  • Be seeking to undergo WB-MRI as a subject in this study in lieu of other covered dedicated diagnostic imaging evaluations when such covered procedures represent more appropriate or standard-of-care procedures by context-specific clinical indication;
  • Be an employee of the study site or the sponsor;
  • Have a medical condition or serious intercurrent illness, or other circumstance that, in the Investigator's judgment, could jeopardize the candidate's safety as a study subject, or that could interfere with study objectives.

Study Design

Enrollment

100000 participants

Anticipated

Interventions and Outcome Measures

Arms

MRI Scan Arm

Whole Body MRI Scan

Interventions

MRI Scan

Whole Body MRI Scan

Primary outcome measure

  • Primary Endpoint and 5-point scale of CSD (Clinically Significant Disease) of CSD diagnosed post-baseline in general population subjects. [ Time Frame: Up to 10 Years ]

Central Contacts and Locations

Central contacts

Kayla MacLeod, BS

(301) 450-4451kayla.macleod@herculesstudy.org

Locations

Hercules Research Center

Recruiting

Watertown, Massachusetts, United States, 02472

Contacts

Sarah Hemeon, BS

617-203-7565hello@herculesstudy.org

Gerimar Leon, BS

(617) 362-3570gerimar.leon@herculesstudy.org

More Information

Sponsor

Hercules

Last update posted

Apr 30, 2025

Last verified

Apr, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Hercules on 2025-04-30.